The ability of tumours to induce new blood-vessel formation has been a major focus of cancer research over the past few decades, and vascular endothelial growth factor (VEGF) is now known to be ...

VEGF-D secretion ... in Celecoxib-treated mice (Supplementary Figure 1). These results are highly consistent with our earlier report of inhibition of tumor growth, tumor-associated ...

In randomized phase III trials two anti-vascular endothelial growth factor (VEGF) approaches have yielded survival benefit in patients with metastatic cancer. In one approach, the addition of ...

The liver breaks down dietary fructose into lipids that are used by cancer cells to boost their growth in mice. Sneha Khedkar is an Assistant Editor at The Scientist. She has a Master's degree in ...

Manipulating the immune system to treat cancer has generated phenomenal responses in some patients, including complete cures, ...